Skip to content

Disc Medicine IRON Increase (Decrease) in Prepaid Expense and Other Assets

Increase (Decrease) in Prepaid Expense and Other Assets at other companies

Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$1.92M+102%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$2.46M+15.6%
Beam Therapeutics logo
Beam TherapeuticsBEAM
$31.86M+65,122%
Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
$6.38M+282%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
BridgeBio Pharma logo
BridgeBio PharmaBBIO

Other financials

Income statement

See full
Operating income-$69.5M-74.0%
Net income-$63.5M-86.3%
EPS (diluted)-$1.65-61.8%

Balance sheet

See full
Cash & equivalents$88.9M-27.5%
Total debt$31.1M+1.4%
Total equity$688.4M+4.3%
Total assets$750.2M+5.8%

Cash flow

See full
Operating cash flow-$62.2M-50.4%
CapEx--100%
Free cash flow-$62.2M-47.4%

Valuation

See full
Market cap$2.69B+42.2%

Returns & leverage

See full
Return on equity-35.8%+41.3pp
Debt / equity0.0×
Current ratio24×-13.6×

Where this comes from

Reported directly by Disc Medicine in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Disc Medicine’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Disc Medicine's increase (decrease) in prepaid expense and other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Disc Medicine's increase (decrease) in prepaid expense and other assets?
Disc Medicine (IRON) reported increase (decrease) in prepaid expense and other assets of $4.55M in Q1 2026.
How has Disc Medicine's increase (decrease) in prepaid expense and other assets changed year-over-year?
Disc Medicine's increase (decrease) in prepaid expense and other assets decreased by 37.1% year-over-year, from $7.23M to $4.55M.
What is the long-term trend for Disc Medicine's increase (decrease) in prepaid expense and other assets?
Over 2 years (2022 to 2025), Disc Medicine's increase (decrease) in prepaid expense and other assets has grown at a 413.8% compound annual growth rate (CAGR), from -$352K to $9.29M.
What does increase (decrease) in prepaid expense and other assets mean?
This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.